Chien-Wei Su - Search Results

Year	Number of Results
2002	2
2006	1
2007	2
2008	9
2009	13
2010	13
2011	12
2012	19
2013	18
2014	10
2015	19
2016	9
2017	13
2018	16
2019	19
2020	23
2021	18
2022	18
2023	11
2024	5

1

Conventional and machine-learning based risk score for patients with early-stage hepatocellular carcinoma.

Ho CT, Tan EC, Lee PC, Chu CJ, Huang YH, Huo TI, Su YH, Hou MC, Wu JC, Su CW. Ho CT, et al. Among authors: su cw. Clin Mol Hepatol. 2024 Apr 11. doi: 10.3350/cmh.2024.0103. Online ahead of print. Clin Mol Hepatol. 2024. PMID: 38600872 Free article.

2

Risk factors associated with hepatitis D virus infection and preventive strategies in Mongolia.

Su CW, Ochirkhuree B, Namdag B, Badamnachin B, Ganbold S, Gidaagaya S, Ganbold A, Yang SS, Duger D, Wu JC. Su CW, et al. J Chin Med Assoc. 2024 Feb 26. doi: 10.1097/JCMA.0000000000001073. Online ahead of print. J Chin Med Assoc. 2024. PMID: 38417133

3

Correction to: Risk scores to predict HCC and the benefits of antiviral therapy for CHB patients in gray zone of treatment guidelines.

Teng W, Chang TT, Yang HI, Peng CY, Su CW, Su TH, Hu TH, Yu ML, Yang HC, Wu JC. Teng W, et al. Among authors: su cw. Hepatol Int. 2024 Jan 22. doi: 10.1007/s12072-023-10634-6. Online ahead of print. Hepatol Int. 2024. PMID: 38252366 No abstract available.

4

Prognostic Nutritional Index as a Prognostic Factor for Very Early-Stage Hepatocellular Carcinoma.

Ho CT, Chia-Hui Tan E, Lee PC, Chu CJ, Huang YH, Huo TI, Hou MC, Wu JC, Su CW. Ho CT, et al. Among authors: su cw. Clin Transl Gastroenterol. 2024 Apr 1;15(4):e00678. doi: 10.14309/ctg.0000000000000678. Clin Transl Gastroenterol. 2024. PMID: 38240325 Free PMC article.

5

Analyzing risk factors and developing a stratification system for hepatocellular carcinoma recurrence after interferon-free direct-acting antiviral therapy in chronic hepatitis C patients.

Luan CH, Su PS, Chu CJ, Lin CC, Su CW, Luo JC, Lee IC, Chi CT, Lee SD, Wang YJ, Lee FY, Huang YH, Hou MC. Luan CH, et al. Among authors: su cw. J Chin Med Assoc. 2024 Apr 1;87(4):357-368. doi: 10.1097/JCMA.0000000000001051. Epub 2024 Jan 5. J Chin Med Assoc. 2024. PMID: 38180018

6

Antiviral therapy reduces hepatocellular carcinoma through suppressing hepatitis B virus replication may improve ER stress, mitochondrial and metabolic dysfunctions and decrease p62 in hybridized mice with single HBV transgene and miR-122.

Liang YJ, Chiou YW, Chiu AP, Shiao MS, Teng W, Lin CW, Cheng ML, Huang YH, Liang KH, Su CW, Lai CY, Chen CL, Wu JC. Liang YJ, et al. Among authors: su cw. J Med Virol. 2023 Dec;95(12):e29325. doi: 10.1002/jmv.29325. J Med Virol. 2023. PMID: 38108211

7

Albumin-Based Liver Reserve Models vs. MELD 3.0 in Prognostic Prediction for Hepatocellular Carcinoma Patients with Renal Insufficiency.

Ho SY, Liu PH, Hsu CY, Tseng HT, Huang YH, Su CW, Hou MC, Huo TI. Ho SY, et al. Among authors: su cw. Int J Mol Sci. 2023 Nov 30;24(23):16987. doi: 10.3390/ijms242316987. Int J Mol Sci. 2023. PMID: 38069310 Free PMC article.

8

Surgical resection versus transarterial chemoembolization for patients with hepatocellular carcinoma beyond Milan criteria: prognostic role of tumor burden score.

Ho SY, Liu PH, Hsu CY, Huang YH, Lei HJ, Liao JI, Su CW, Hou MC, Huo TI. Ho SY, et al. Among authors: su cw. Sci Rep. 2023 Aug 24;13(1):13871. doi: 10.1038/s41598-023-41068-7. Sci Rep. 2023. PMID: 37620558 Free PMC article.

9

The outcomes and prognostic factors of patients with hepatocellular carcinoma and Child-Turcotte-Pugh class B.

Fu CC, Chen YJ, Su CW, Wei CY, Chu CJ, Lee PC, Huo TI, Huang YH, Huang HC, Wu JC, Hou MC. Fu CC, et al. Among authors: su cw. J Chin Med Assoc. 2023 Oct 1;86(10):876-884. doi: 10.1097/JCMA.0000000000000975. Epub 2023 Aug 4. J Chin Med Assoc. 2023. PMID: 37537726

10

Residual risk of hepatocellular carcinoma development for chronic hepatitis C patients treated by all oral direct-acting antivirals with sustained virological response.

Luan CH, Su PS, Chu CJ, Lin CC, Su CW, Lee SD, Wang YJ, Lee FY, Huang YH, Hou MC. Luan CH, et al. Among authors: su cw. J Chin Med Assoc. 2023 Sep 1;86(9):795-805. doi: 10.1097/JCMA.0000000000000965. Epub 2023 Jul 19. J Chin Med Assoc. 2023. PMID: 37466658

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

208 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

208 results

Results by year